Aft Forsyth & Sober’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-150
Closed -$40K 38
2020
Q2
$40K Buy
+150
New +$40K 0.28% 46
2020
Q1
Sell
-290
Closed -$88K 39
2019
Q4
$88K Buy
+290
New +$79.8K 0.08% 44

Other funds holding ELV

Aft Forsyth & Sober's ELV Position: Q3 2020 in Review

Aft Forsyth & Sober sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 150 shares — an estimated $40K sold.

Aft Forsyth & Sober first reported a position in ELV in Q4 2019 and held it in 2 quarters. The position peaked at $88K in Q4 2019. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Aft Forsyth & Sober reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Aft Forsyth & Sober sold 150 Elevance Health shares in Q3 2020, an estimated $40K.
  • Aft Forsyth & Sober first reported a position in Elevance Health in Q4 2019 and held it in 2 quarters.
  • Aft Forsyth & Sober's Elevance Health position peaked at $88K in Q4 2019.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Aft Forsyth & Sober's 13F filing for Q3 2020, filed 14 Oct 2020.